Summary

The author has released its latest research “The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.” The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global oncology therapeutics market. The report analyzes the markets for oncology therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes:
- Annualized market data for the oncology therapeutics market from 2000 to 2008, forecast forward to 2015
- Analysis of the leading therapeutic segments including lung cancer, breast cancer, prostate cancer, colorectal cancer and Non-Hodgkin’s Lymphoma.
- Analysis of the oncology diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the oncology therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, Novartis AG, Sanofi-aventis, Amgen, AstraZeneca, Merck & Co, Pfizer Inc, Celgene Corporation, Bristol-Myers Squibb and Eli Lilly
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global oncology therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Table Of Contents

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 8
1.2 List of Figures 10
2 Global Oncology Therapeutics Market: Introduction 13
2.1 GBI Research Report Guidance 14
3 Global Oncology Therapeutics Market: Cancer Epidemiology 15
4 Global Oncology Therapeutics Market: Market Overview 16
4.1 Introduction 16
4.2 Revenue Forecasts for the Global Oncology Therapeutics Market 18
4.2.1 Sales Value 18
4.2.2 Sales Volume 19
4.2.3 Drug Prices 20
4.2.4 Treatment Usage Patterns 21
4.3 Generics in Oncology Therapeutics Market 25
4.4 Oncology therapeutics market Drivers 26
4.4.1 Steady Increase in the Ageing Population 26
4.4.2 New Innovative Products in the Pipeline 27
4.4.3 Rapid Uptake of Targeted Therapies in Key Cancer Indications 27
4.5 Oncology Therapeutics Market Restraints 27
4.5.1 The US Cancer Incidence Moving Towards a Decelerating Growth Rate 27
4.5.2 Patent Expirations and Entry of Generics Pose as a Severe Threat for Primary Manufacturers 28
4.5.3 Restrictive Pricing and Reimbursement Policies Causing Serious Problems in the Oncology Therapeutics Market Growth 29
4.5.4 More Than 80 Molecules to be Launched Over the Next Seven years - Leading to More Competition 30
5 Global Oncology Therapeutics Market: Pricing and Reimbursement 31
5.1 Average Cost of Drug Treatment 31
5.2 The US 33
5.2.1 Pricing 33
5.2.2 Medicare Reimbursement on Cancer Drugs 33
5.3 Europe 34
5.3.1 Pricing and Reimbursement - Country Analysis 36
6 Global Oncology Therapeutics Market: Geographical Landscape 41
6.1 Geographic Break-up 41
6.2 The US 42
6.2.1 Sales Value 42
6.2.2 Sales Volume 43
6.2.3 Drug Prices 44
6.2.4 Treatment Usage Patterns 45
6.3 Top Five European Countries 49
6.3.1 Sales Value 49
6.3.2 Sales Volume 51
6.3.3 Drug Prices 51
6.3.4 Treatment Usage Patterns 53
6.4 Japan 57
6.4.1 Sales Value 57
6.4.2 Sales Volume 58
6.4.3 Drug Prices 59
6.4.4 Treatment Usage Patterns 60
7 Global Oncology Therapeutics Market: Therapeutic Landscape 65
7.1 Breast Cancer Therapeutics Market 65
7.1.1 Introduction 65
7.1.2 Sales Value 67
7.1.3 Sales Volume 68
7.1.4 Drug Prices 69
7.1.5 Treatment Usage Patterns 70
7.2 Non-Hodgkin’s Lymphoma Therapeutics Market 75
7.2.1 Introduction 75
7.2.2 Sales Value 76
7.2.3 Sales Volume 78
7.2.4 Drug Prices 78
7.2.5 Treatment Usage Patterns 79
7.3 Colorectal Cancer Therapeutics Market 83
7.3.1 Introduction 83
7.3.2 Sales Value 87
7.3.3 Sales Volume 88
7.3.4 Drug Prices 89
7.3.5 Treatment Usage Patterns 90
7.4 Prostate Cancer Therapeutics Market 94
7.4.1 Introduction 94
7.4.2 Sales Value 96
7.4.3 Sales Volume 97
7.4.4 Drug Prices 98
7.4.5 Treatment Usage Patterns 99
7.5 Lung Cancer Therapeutics Market 103
7.5.1 Introduction 103
7.5.2 Sales Value 107
7.5.3 Sales Volume 108
7.5.4 Drug Prices 109
7.5.5 Treatment Usage Patterns 109
8 Global Oncology Therapeutics Market: Pipeline Analysis 115
8.1 Introduction 115
8.1.1 RandD Strategies 116
8.2 RandD Trends 117
8.2.1 Discovery of Unknown Mutations that Play Key Role in Cancers 117
8.2.2 Pairing Therapeutics and Diagnostics 118
8.3 Profiles of Key Late-Stage Drugs 119
8.3.1 Angiogenesis and Multi-Targeted Kinase Inhibitors 119
8.3.2 Hsp90 Inhibitors 121
8.3.3 Insulin-like Growth Factor Receptor Inhibitors 122
8.3.4 Hedgehog Inhibitors 124
8.3.5 Immuno-conjugates 124
8.4 Insights into Most Promising Drugs 125
8.4.1 Provenge 125
8.4.2 Denosumab 127
8.4.3 Tasigna 129
8.4.4 Aflibercept 130
8.4.5 Tykerb 131
9 Global Oncology Therapeutics Market: Competitive Landscape 134
9.1 Evolving competitive landscape 134
9.1.1 Major players 135
9.1.2 Key areas focused for RandD 135
9.1.3 Challenges faced by brands in marketing the oncology products 136
9.2 Market Share Analysis 138
9.2.1 Rituxan, Avastin, Revlimid and Herceptin are expected to lead the market through 2015 139
9.3 Roche/Genentech 141
9.3.1 Key Oncology Drugs 142
9.3.2 Key Indications of Interest 145
9.3.3 Pipeline Analysis 146
9.3.4 Key Strategies 148
9.4 Novartis 148
9.4.1 Key Oncology Drugs 149
9.4.2 Key Indications of Interest 152
9.4.3 Pipeline Analysis 152
9.4.4 Key Strategies 153
9.5 Sanofi-Aventis 155
9.5.1 Key Oncology Drugs 156
9.5.2 Key Indications of Interest 157
9.5.3 Pipeline Analysis 158
9.5.4 Key Strategies 159
9.6 Amgen 160
9.6.1 Key Oncology Drugs 161
9.6.2 Key of Indications of Interests 163
9.6.3 Pipeline Analysis 163
9.6.4 Key Strategies 165
9.7 Astra Zeneca 165
9.7.1 Key Oncology Drugs 166
9.7.2 Key Indications of Interests 167
9.7.3 Pipeline Analysis 168
9.7.4 Key Strategies 169
10 . Global Oncology Therapeutics Market: MandA Landscape 170
10.1 Overview 170
10.1.1 Pfizer Acquires Wyeth 170
10.1.2 Roche Acquires Genentech 170
10.1.3 Takeda Pharmaceutical Acquires IDM Pharma 171
10.1.4 EUS Pharma Acquires Cytogen Corporation 171
10.1.5 GlaxoSmithKline Acquires Sirtris Pharmaceuticals 171
10.1.6 GlaxoSmithKline Acquires Bristol-Myers Squibb (Egyptian unit) 171
10.1.7 Pfizer Enters into an Agreement with Aurobindo Pharma and Claris Life Sciences 171
10.1.8 Teva Pharmaceuticals Acquires Barr 171
10.1.9 Sanofi-Aventis Acquires Medley 171
10.2 RandD Licensing Agreements 171
10.2.1 Deals by Phase 172
10.2.2 Deals by Geography 172
10.2.3 Deals by Licensing Type 173
10.2.4 Deals by Value ($) 174
10.2.5 Preclinical 174
10.2.6 Phase I 176
10.2.7 Phase II 177
10.2.8 Phase III 178
10.2.9 Approved 180
11 . Global Oncology Therapeutics Market: Appendix 182
11.1 Research Methodology 182
11.2 Geographical Scope 182
11.3 Coverage 182
11.4 Secondary Research 183
11.5 Primary Research 183
11.6 Models 183
11.7 Forecasts 184
11.8 Expert Panel Validation 184
11.9 Contact Us 184
11.10 Disclaimer 184


1.1 List of Tables
Table 1: Oncology Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2008 17
Table 2: Oncology Therapeutics Market, Global, Revenue Forecasts ($ m), 2008-2015 17
Table 3: Oncology Therapeutics Market, Global, Sales Volume (million), 2000-2008 18
Table 4: Oncology Therapeutics Market, Global, Sales Volume (million), 2009-15 18
Table 5: Oncology Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 19
Table 6: Oncology Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 19
Table 7: Oncology Therapeutics Market, Global, Treatment Usage Patterns, Historic 2000-2008 20
Table 8: Oncology Therapeutics Market, Global, Treatment Usage Patterns, Forecasts 2008-2015 21
Table 9: Oncology Therapeutics Market, Global, Generics Sales Forecast, 2008-2015 25
Table 10: Oncology Therapeutics Market, The US, Major Drug Patent Expirations, 2009-19 28
Table 11: Oncology Therapeutics, Global, Annual Cost of Therapy ($), 2000-2008 31
Table 12: Oncology Therapeutics, Global, Annual Cost of Therapy ($), 2008-2015 31
Table 13: Direct Medical Costs for Cancer Care in Select European Countries - 2008 33
Table 14: Reimbursement Rates based on Pharamco-economic Evaluation - 2008 37
Table 15: Italy Reimbursement Coverage System - 2008 38
Table 16: Spain Pharmaceutical Pricing System - 2008 39
Table 17: Italy Reimbursement Coverage System - 2008 39
Table 18: Oncology Therapeutics Market, Global, Revenue Break-up by Geography ($ m), 2000-2008 40
Table 19: Oncology Therapeutics Market, Global, Revenue Break-up by Geography ($ m), 2008-2015 41
Table 20: Oncology Therapeutics Market, The US, Revenue Forecasts ($ m), 2000-2008 42
Table 21: Oncology Therapeutics Market, The US, Revenue Forecasts ($ m), 2008-2015 42
Table 22: Oncology Therapeutics Market, The US, Volume Forecasts (million), 2000-2008 43
Table 23: Oncology Therapeutics Market, The US, Volume Forecasts (million), 2008-2015 43
Table 24: Oncology Therapeutics Market, The US, Average Cost per Dose ($), 2000-2008 44
Table 25: Oncology Therapeutics Market, The US, Average Cost per Dose ($), 2008-2015 44
Table 26: Oncology Therapeutics Market, The US, Treatment Usage Patterns, 2000-2008 45
Table 27: Oncology Therapeutics Market, The US, Treatment Usage Patterns, 2008-2015 45
Table 28: Oncology Therapeutics Market, Europe, Revenue Forecasts ($ m), 2000-2008 49
Table 29: Oncology Therapeutics Market, Europe, Revenue Forecasts ($ m), 2008-2015 49
Table 30: Oncology Therapeutics Market, Europe, Volume Forecasts (million), 2000-2008 50
Table 31: Oncology Therapeutics Market, Europe, Volume Forecasts (million), 2008-2015 50
Table 32: Oncology Therapeutics Market, Europe, Average Cost per Dose ($), 2000-2008 51
Table 33: Oncology Therapeutics Market, Europe, Average Cost per Dose ($), 2008-2015 52
Table 34: Oncology Therapeutics Market, Europe, Treatment Usage Patterns, 2000-2008 52
Table 35: Oncology Therapeutics Market, Europe, Treatment Usage Patterns, 2008-2015 53
Table 36: Oncology Therapeutics Market, Japan, Revenue ($ bn), 2000-2008 57
Table 37: Oncology Therapeutics Market, Japan, Revenue ($ bn), 2008-2015 57
Table 38: Oncology Therapeutics Market, Japan, Volume Forecasts (million), 2000-2008 58
Table 39: Oncology Therapeutics Market, Japan, Volume Forecasts (million), 2008-2015 58
Table 40: Oncology Therapeutics Market, Japan, Average Cost per Dose ($), 2000-2008 59
Table 41: Oncology Therapeutics Market, Japan, Average Cost per Dose ($), 2009-15 59
Table 42: Oncology Therapeutics Market, Japan, Treatment Usage Patterns, 2000-2008 60
Table 43: Oncology Therapeutics Market, Japan, Treatment Usage Patterns, 2008-2015 60
Table 44: Breast Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage 65
Table 45: Breast Cancer Therapeutics Market, Global, Revenue ($ bn), 2000-2008 67
Table 46: Breast Cancer Therapeutics Market, Global, Revenue ($ bn), 2008-2015 67
Table 47: Breast Cancer Therapeutics Market, Global, Volume (million), 2000-2008 68
Table 48: Breast Cancer Therapeutics Market, Global, Volume (million), 2008-2015 68
Table 49: Breast Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 69
Table 50: Breast Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 69
Table 51: Breast Cancer Therapeutics Market, Global, Usage Patterns, 2000-2008 70
Table 52: Breast Cancer Therapeutics Market, Global, Usage Patterns, 2008-2015 71
Table 53: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Cancer Categorized by Disease Stage 74
Table 54: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Revenue ($ bn), 2000-2008 76
Table 55: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Revenue ($ bn), 2008-2015 76
Table 56: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Volume (million), 2000-2008 77
Table 57: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Volume (million), 2008-2015 77
Table 58: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 78
Table 59: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 78
Table 60: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Usage Patterns, 2000-2008 79
Table 61: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Usage Patterns, 2008-2015 80
Table 62: Colorectal Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage 84
Table 63: Colorectal Cancer Therapeutics Market, Global, Revenue ($ bn), 2000-2008 86
Table 64: Colorectal Cancer Therapeutics Market, Global, Revenue ($ bn), 2008-2015 86
Table 65: Colorectal Cancer Therapeutics Market, Global, Volume (million), 2000-2008 87
Table 66: Colorectal Cancer Therapeutics Market, Global, Volume (million), 2008-2015 87
Table 67: Colorectal Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 88
Table 68: Colorectal Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 88
Table 69: Colorectal Cancer Therapeutics Market, Global, Usage Patterns, 2000-2008 90
Table 70: Colorectal Cancer Therapeutics Market, Global, Usage Patterns, 2008-2015 90
Table 71: Prostate Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage 94
Table 72: Prostate Cancer Therapeutics Market, Global, Revenue ($ bn), 2000-2008 96
Table 73: Prostate Cancer Therapeutics Market, Global, Revenue ($ bn), 2008-2015 96
Table 74: Prostate Cancer Therapeutics Market, Global, Volume (million), 2000-2008 96
Table 75: Prostate Cancer Therapeutics Market, Global, Volume (million), 2008-2015 97
Table 76: Prostate Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 97
Table 77: Prostate Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 98
Table 78: Prostate Cancer Therapeutics Market, Global, Usage Patterns, 2000-2008 99
Table 79: Prostate Cancer Therapeutics Market, Global, Usage Patterns, 2008-2015 99
Table 80: Lung Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage 103
Table 81: Lung Cancer Therapeutics Market, Global, NSCLC Treatment by Stage of the Disease 105
Table 82: Lung Cancer Therapeutics Market, Global, Revenue ($ bn), 2000-2008 106
Table 83: Lung Cancer Therapeutics Market, Global, Revenue ($ bn), 2008-2015 107
Table 84: Lung Cancer Therapeutics Market, Global, Volume (million), 2000-2008 107
Table 85: Lung Cancer Therapeutics Market, Global, Volume (million), 2008-2015 107
Table 86: Lung Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 108
Table 87: Lung Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 108
Table 88: Lung Cancer Therapeutics Market, Global, Usage Patterns, 2000-2008 110
Table 89: Lung Cancer Therapeutics Market, Global, Usage Patterns, 2008-2015 110
Table 90: Oncology Therapeutics Market, Global, Top 10 Brands’ Sales ($ m), 2006-2008 139
Table 91: Oncology Therapeutics Market, Global, Roche/Genentech Sales, 2006-2015 141
Table 92: Oncology Therapeutics Market, Global, Novartis, Sales ($ m), 2006-2015 148
Table 93: Oncology Therapeutics Market, Global, Sanofi-Aventis, Sales ($ m), 2006-15 155
Table 94: Oncology Therapeutics Market, Global, Amgen, Sales ($ m), 2006-2015 160
Table 95: Oncology Therapeutics Market, Global, AstraZeneca, Sales ($ m), 2006-2015 165
Table 96: Oncology Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008-09 174
Table 97: Oncology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase I, 2008-09 175
Table 98: Oncology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase II, 2008-09 176
Table 99: Oncology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase III, 2008-09 178
Table 100: Oncology Therapeutics Market, Global, Licensing Agreements for Approved Drugs, 2008-09 179


1.2 List of Figures
Figure 1: Global Cancer Incidence by Tumor Type - 2007 15
Figure 2: Global Cancer Mortality by Tumor Type - 2007 15
Figure 3: Oncology Therapeutics Market, Global, Drivers and Restraints, 2008 16
Figure 4: Oncology Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2015 17
Figure 5: Oncology Therapeutics Market, Global, Sales Volume (million), 2000-2015 18
Figure 6: Oncology Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 19
Figure 7: Oncology Therapeutics Market, Global, Treatment Usage Patterns, 2000-2015 20
Figure 8: Oncology Therapeutics Market, Global, Diseased Population, 2000-2015 21
Figure 9: Oncology Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 22
Figure 10: Oncology Therapeutics Market, Global, Diagnosis Population, 2000-2015 23
Figure 11: Oncology Therapeutics Market, Global, Prescription Population, 2000-2015 24
Figure 12: Oncology Therapeutics Market, Global, Generics Sales Forecast, 2008-2015 24
Figure 13: Oncology Therapeutics Market, Global, Drivers and Restraints, 2008-2015 25
Figure 14: Oncology Therapeutics Market, Global, Future Drivers and Restraints of the market, 2015 29
Figure 15: Oncology Therapeutics, Global, Annual Cost of Therapy ($), 2000-2015 31
Figure 16: Oncology Therapeutics, The US, Cost of Treatment ($), 2000-2015 32
Figure 17: Pricing and Reimbursement Trends of Top Five Countries in the EU - 2008 34
Figure 18: Oncology Therapeutics, Top Five Countries in the EU , Cost of Treatment ($), 2000-2015 34
Figure 19: UK NICE Patients Access Schemes by Type 36
Figure 20: Oncology Therapeutics Market, Global, Revenue Break-up by Geography ($ m), 2000-2015 40
Figure 21: Oncology Therapeutics Market, Global, Segmentation by Geography - 2008 and 2015 41
Figure 22: Oncology Therapeutics Market, The US, Revenue Forecasts ($ m), 2000-2015 42
Figure 23: Oncology Therapeutics Market, The US, Volume Forecasts (million), 2000-2015 43
Figure 24: Oncology Therapeutics Market, The US, Average Cost per Dose ($), 2000-2015 44
Figure 25: Oncology Therapeutics Market, The US, Treatment Usage Patterns, 2000-2015 45
Figure 26: Oncology Therapeutics Market, the US, Diseased Population, 2000-2015 46
Figure 27: Oncology Therapeutics Market, the US, Treatment Seeking Population, 2000-2015 46
Figure 28: Oncology Therapeutic Market, The US, Diagnosis Population, 2000-2015 47
Figure 29: Oncology Therapeutic Market, The US, Prescription Population, 2000-2015 48
Figure 30: Oncology Therapeutics Market, The US, Drivers and Restraints 48
Figure 31: Oncology Therapeutics Market, Europe, Revenue Forecasts ($ m), 2000-2015 49
Figure 32: Oncology Therapeutics Market, Europe, Volume Forecasts (million), 2000-2015 50
Figure 33: Oncology Therapeutics Market, Europe, Average Cost per Dose ($), 2000-2015 51
Figure 34: Oncology Therapeutics Market, Europe, Treatment Usage Patterns, 2000-2015 52
Figure 35: Oncology Therapeutics Market, Europe, Diseased Population, 2000-2015 53
Figure 36: Oncology Therapeutics Market, Europe, Treatment Seeking Population, 2000-2015 54
Figure 37: Oncology Therapeutics Market, Europe, Diagnosis Population, 2000-2015 54
Figure 38: Oncology Therapeutics Market, Europe, Prescription Population, 2000-2015 55
Figure 39: Oncology Therapeutics Market, Europe, Drivers and Restraints, 2008-2015 56
Figure 40: Oncology Therapeutics Market, Japan, Revenue ($ bn), 2000-2015 57
Figure 41: Oncology Therapeutics Market, Japan, Volume Forecasts (million), 2000-2015 58
Figure 42: Oncology Therapeutics Market, Japan, Average Cost per Dose ($), 2000-2015 59
Figure 43: Oncology Therapeutics Market, Japan, Treatment Usage Patterns, 2000-2015 60
Figure 44: Oncology Therapeutics Market, Japan, Diseased Population, 2000-2015 61
Figure 45: Oncology Therapeutics Market, Japan, Treatment Seeking Population, 2000-2015 61
Figure 46: Oncology Therapeutics Market, Japan, Diagnosis Population, 2000-2015 62
Figure 47: Oncology Therapeutics Market, Japan, Prescription Population, 2000-2015 63
Figure 48: Oncology Therapeutics Market, Global, Market Share of Major Indications, 2008 64
Figure 49: Breast Cancer Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2015 67
Figure 50: Breast Cancer Therapeutics Market, Global, Volume (million), 2000-2015 68
Figure 51: Breast Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 69
Figure 52: Breast Cancer Therapeutics Market - Major Drivers and Restraints - 2008-2015 70
Figure 53: Breast Cancer Therapeutics Market, Global, Usage Patterns, 2000-2015 70
Figure 54: Breast Cancer Therapeutics Market, Global, Diseased Population, 2008-2015 71
Figure 55: Breast Cancer Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 72
Figure 56: Breast Cancer Therapeutics Market, Global, Diagnosis Population, 2000-2015 73
Figure 57: Breast Cancer Therapeutics Market, Global, Prescription Population, 2000-2015 73
Figure 58: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2015 76
Figure 59: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Volume (million), 2000-2015 77
Figure 60: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 78
Figure 61: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Drivers and Restraints, 2008-2015 79
Figure 62: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Usage Patterns, 2000-2015 79
Figure 63: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Diseased Population, 2000-2015 80
Figure 64: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 81
Figure 65: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Diagnosis Population, 2000-2015 81
Figure 66: Non-Hodgkin’s Lymphoma Therapeutics Market, Global, Prescription Population, 2000-2015 82
Figure 67: Colorectal Cancer Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2015 86
Figure 68: Colorectal Cancer Therapeutics Market, Global, Volume (million), 2000-2015 87
Figure 69: Colorectal Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 88
Figure 70: Colorectal Cancer Therapeutics Market, Global, Drivers and Restraints, 89
Figure 71: Colorectal Cancer Therapeutics Market, Global, Usage Patterns, 2000-2015 89
Figure 72: Colorectal Cancer Therapeutics Market, Global, Diseased Population, 2000-2015 90
Figure 73: Colorectal Cancer Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 91
Figure 74: Colorectal Cancer Therapeutics Market, Global, Diagnosis Population, 2000-2015 92
Figure 75: Colorectal Cancer Therapeutics Market, Global, Prescription Population, 2000-2015 93
Figure 76: Prostate Cancer Therapeutics Market, Global, Revenue ($m), 2000-2015 95
Figure 77: Prostate Cancer Therapeutics Market, Global, Volume (million), 2000-2015 96
Figure 78: Prostate Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 97
Figure 79: Prostate Cancer Therapeutics Market, Major Drivers and Restraints, 2008-2015 98
Figure 80: Prostate Cancer Therapeutics Market, Global, Usage Patterns, 2000-2015 99
Figure 81: Prostate Cancer Therapeutics Market, Global, Diseased Population, 2000-2015 100
Figure 82: Prostate Cancer Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 100
Figure 83: Prostate Cancer Therapeutics Market, Global, Diagnosis Population, 2000-2015 101
Figure 84: Prostate Cancer Therapeutics Market, Global, Prescription Population, 2000-2015 102
Figure 85: Lung Cancer Therapeutics Market, Global, Revenue ($ m), 2000-2015 106
Figure 86: Lung Cancer Therapeutics Market, Global, Volume (million), 2000-2015 107
Figure 87: Lung Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 108
Figure 88: Lung Cancer Therapeutics Market - Major Drivers and Restraints - 2008-2015 109
Figure 89: Lung Cancer Therapeutics Market, Global, Usage Patterns, 2000-2015 109
Figure 90: Lung Cancer Therapeutics Market, Global, Diseased Population, 2000-2015 110
Figure 91: Lung Cancer Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 111
Figure 92: Lung Cancer Therapeutics Market, Global, Diagnosis Population, 2000-2015 112
Figure 93: Lung Cancer Therapeutics Market, Global, Prescription Population, 2000-2015 113
Figure 94: Oncology Therapeutics Market, Global, RandD Pipeline (Number and %), September 2009 114
Figure 95: Oncology Therapeutics Market, Global, Strategies for Successful Product Launches in Cancer Market 115
Figure 96: Oncology Therapeutics Market, Global, Cancer Tumors Segmented by their Market and Degree of Unmet Needs 116
Figure 97: Oncology Therapeutics Market, Global, Top Three Companies Landscape, 2008 133
Figure 98: Oncology Therapeutics Market, Global, Top 10 Companies Sales ($ m), 2006-08 134
Figure 99: Oncology Therapeutics Market, Global, RandD Pipeline (NCE) of the Top 10 Companies, 2009 135
Figure 100: Oncology Therapeutics Market, Global, Key Target Therapies Launched, 1998-2009 136
Figure 101: Oncology Therapeutics Market, Global, Market Trends 137
Figure 102: Oncology Therapeutics Market, Global, Market Share Analysis, 2008 138
Figure 103: Oncology Therapeutics Market, Global, Top 5 Companies Benchmarking, 2008 138
Figure 104: Oncology Therapeutics Market, Global, Top 10 Brands’ Sales ($ m), 2006-08 139
Figure 105: Oncology Therapeutics Market, Global, Roche Oncology Drugs Segmentation, 2008 140
Figure 106: Oncology Therapeutics Market, Global, Roche/Genentech Sales, 2006-15 141
Figure 107: Oncology Therapeutics Market, Global, Roche/Genentech, Number of Products in Clinical Trails by Indication, June 2009 145
Figure 108: Oncology Therapeutics Market, Global, Roche/Genentech, Follow on Indications, June 2009 146
Figure 109: Oncology Therapeutics Market, Global, Roche/Genentech, Phase-wise Analysis, June 2009 147
Figure 110: Oncology Therapeutics Market, Global, Novartis, Sales ($ m), 2006-15 148
Figure 111: Oncology Therapeutics Market, Global, Novartis, RandD Pipeline by Indication, June 2009 151
Figure 112: Oncology Therapeutics Market, Global, Novartis, RandD Pipeline Phase-wise Analysis, June 2009 152
Figure 113: Oncology Therapeutics Market, Global, Sanofi Aventis, Sales Segmentation by Brand ($ m) - 2008 154
Figure 114: Oncology Therapeutics Market, Global, Sanofi-Aventis, Sales ($ m), 2006-15 155
Figure 115: Oncology Therapeutics Market, Global, Sanofi-Aventis, RandD Pipeline by Indication, June 2009 156
Figure 116: Oncology Therapeutics Market, Global, Sanofi-Aventis, RandD Pipeline by Phase, June 2009 158
Figure 117: Oncology Therapeutics Market, Global, Amgen, Sales Segmentation by Brand, 2008 159
Figure 118: Oncology Therapeutics Market, Global, Amgen, Sales ($ m), 2006-15 160
Figure 119: Oncology Therapeutics Market, Global, RandD Pipeline by Indication, June 2009 162
Figure 120: Oncology Therapeutics Market, Global, Amgen, RandD Pipeline by Phase, June 2009 163
Figure 121: Oncology Therapeutics Market, Global, AstraZeneca, Sales Segmentation by Brand, 2008 164
Figure 122: Oncology Therapeutics Market, Global, AstraZeneca, Sales ($ m), 2006-2015 165
Figure 123: Oncology Therapeutics Market, Global, RandD Pipeline by Indication, June 2009 167
Figure 124: Oncology Therapeutics Market, Global, AstraZeneca, RandD Pipeline by Phase, June 2009 167
Figure 125: Oncology Therapeutics Market, Global, Major MandA Deals, 2008-09 169
Figure 126: Oncology Therapeutics Market, Global, Major Licensing Agreements By Each Phase, 2008-09 171
Figure 127: Oncology Therapeutics Market, Global, Major Licensing Agreements By Geography, 2008-09 172
Figure 128: Oncology Therapeutics Market, Global, Major Licensing Agreements By Type, 2008-09 172
Figure 129: Oncology Therapeutics Market, Global, Major Licensing Agreements By Value, 2008-09 173
Figure 130: GBI Research Methodology 181

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

OpportunityAnalyzer: Allergic Conjunctivitis - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Allergic Conjunctivitis - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • September 2014
  • by Global Data

OpportunityAnalyzer: Allergic Conjunctivitis - Opportunity Analysis and Forecasts to 2018 Summary The allergic conjunctivitis market has remained relatively static over the last few years, due to a limited ...

Global Depression Therapy & Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

Global Depression Therapy & Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

  • $ 7 000
  • Industry report
  • November 2014
  • by Occams

Depression is a state of emotion that affects thoughts, actions and often, sleeping patterns of affected individual. Depression affects behavior in terms of loss of appetite, being in a constant state ...

Photomedicine: Technologies and Global Markets

Photomedicine: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research study provides a comprehensive analysis of the market of photomedicine. It addresses the drivers and limiters of the market and offers an exhaustive analysis of both drugs and medical ...

Stem Cell Therapeutics Markets

October 2014 $ 3 995

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.